VAP prevention â non-antimicrobial methods

More documents

Recommendations

Info

Feasibility and effects of the semirecumbent position to prevent <strong>VAP</strong>: a randomized study. van Nieuwenhoven CA et al, Crit Care Med 2006; 34: 396-402 • Prospective multicentre trial of 221 patients • 45 o vs. 10 o NS NS • Target of 45 o not achieved 85% of the time • On average achieved 28 o vs. 10 o
Benefits seen in ‘Drakulovic’ trial were not sustained… % Valencia M et al, Crit Care Med 2007; 35: 1543-9
Page 1 and 2: Monday 6 th September 2010 London V
Page 3 and 4: 1970 - 1980’s VAP is an iatrogeni
Page 5 and 6: Pepsin - in the lungs! • Intra-tr
Page 7: Supine body position as a risk fact
Page 11 and 12: Oropharyngeal cleansing with 0.2% c
Page 13 and 14: Draft High Impact Intervention No 5
Page 15 and 16: Silver-coated ET tubes & VAP
Page 17 and 18: Silver-coated ET tubes & VAP VAP @
Page 19 and 20: Pneumonia in intubated patients: ro
Page 22 and 23: Subglottic Secretion Drainage Tubes
Page 24 and 25: Subglottic Secretion Drainage & VAP
Page 26 and 27: Kimberly-Clark £~15 ~£6 ~£10 Cov
Page 28 and 29: Stress ulcer prophylaxis & VAP VAP/
Page 30 and 31: The UK TracMan trial N=909 Early (D
Page 32 and 33: Tight glucose control to prevent VA
Page 34 and 35: Tight glucose control to prevent VA
Page 36 and 37: Selective Decontamination to preven

VAP prevention â non-antimicrobial methods

Create successful ePaper yourself

Delete template?

Save as template?

VAP prevention â non-antimicrobial methods